Magnet.me - Het slimme netwerk waar studenten en professionals hun stage of baan vinden.
Het slimme netwerk waar studenten en professionals hun stage of baan vinden.
Bouw aan je carrière op Magnet.me
Maak een profiel aan en ontvang slimme aanbevelingen op basis van je gelikete vacatures.
An exciting position as a laboratory technician within the ALS Center and the iPSC facility of the Department of Translational Neuroscience.
The focus of this role is to establish and further develop cell models to study disease mechanisms and novel gene-targeted therapies for ALS.
ALS is a rapidly progressive, fatal disease in which motor neurons degenerate. Since 2024, for the first time in 150 years of research, effective gene-targeted therapies have become available for patients with specific mutations in the SOD1 gene (<1% of all ALS patients). In this research line, we develop in vitro patient models to investigate which patients may qualify for these and future gene-targeted therapies.
The laboratory technician will develop a diverse set of skills, including the transdifferentiation of fibroblasts and PBMCs into neurons (iNeurons), screening of antisense oligonucleotides (AONs), and characterization of treatment response through live-cell imaging, staining, and possibly electrophysiological studies or transcriptomic analyses. The infrastructure, expertise, and protocols are already in place, but we hope for an active contribution to further improve these models.
You will work with a diverse group of colleagues with backgrounds in biomedical sciences, medicine, and bioinformatics, both within and outside UMC Utrecht, including the Dutch Center for RNA Therapeutics and Charles River Laboratories. This is based on informal and close collaboration with PhD candidates, postdocs, and fellow laboratory technicians on an equal footing.
At the ALS Center in Utrecht, nearly all people with ALS in the Netherlands are seen, and it is home to the largest ALS research group in Europe. Genetic research into ALS is carried out in an international collaborative setting, in which UMC Utrecht plays a central role. We focus on identifying genetic causes and developing gene-targeted therapies for ALS. To this end, we use (motor) neurons derived from induced pluripotent stem cells from patients, and we are also developing new models through direct transdifferentiation from fibroblasts and PBMCs. The team consists of PhD-students with a (bio)medical background and technicians supervised by both clinical and biomedical researchers. There are international collaborations with academic and pharmaceutical partners.
An enthusiastic and eager-to-learn technician with a completed HBO/associate degree or equivalent in laboratory research, who is motivated to contribute to the development of new cell models for ALS.
Het UMC Utrecht wil bijdragen aan een gezond leven en een gezonde maatschappij, ook voor de generaties na ons. Daarvoor is veel kennis nodig. Als academisch ziekenhuis doen we wetenschappelijk onderzoek naar verschillende ziekten en de werking van onze genen.
Deze bedrijfspagina is automatisch gegenereerd en bevat daarom nog weinig informatie. Je vindt meer informatie over ‘bedrijfsnaam’ op hun website: ‘’Carrierewebsite’’
Bekijk ons aanbod:
Resources:
Change language to: English
Deze pagina is geoptimaliseerd voor mensen uit Nederland. Bekijk de versie geoptimaliseerd voor mensen uit het Verenigd Koninkrijk.